Navigation Links
DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy
Date:12/16/2009

The DNA of a 1st century shrouded man found in a tomb on the edge of the Old City of Jerusalem has revealed the earliest proven case of leprosy. Details of the research will be published December 16 in the PloS ONE Journal.

The molecular investigation was undertaken by Prof. Mark Spigelman and Prof. Charles Greenblatt and of the Sanford F. Kuvin Center for the Study of Infectious and Tropical Diseases at the Hebrew University of Jerusalem, Prof. Carney Matheson and Ms. Kim Vernon of Lakehead University, Canada, Prof. Azriel Gorski of New Haven University and Dr. Helen Donoghue of University College London. The archaeological excavation was led by Prof. Shimon Gibson, Dr. Boaz Zissu and Prof. James Tabor on behalf of the Israel Antiquities Authority and the University of North Carolina at Charlotte.

The burial cave, which is known as the Tomb of the Shroud, is located in the lower Hinnom Valley and is part of a 1st century C.E. cemetery known as Akeldama or 'Field of Blood' (Matthew 27:3-8; Acts 1:19) - next to the area where Judas is said to have committed suicide. The tomb of the shrouded man is located next to the tomb of Annas, the high priest (6-15 C.E.), who was the father in law of Caiaphas, the high priest who betrayed Jesus to the Romans. It is thus thought that this shrouded man was either a priest or a member of the aristocracy. According to Prof. Gibson, the view from the tomb would have looked directly toward the Jewish Temple.

No second burial

What is particularly rare about this tomb is that it was clear this man, which is dated by radiocarbon methods to 1-50 C.E., did not receive a secondary burial. Secondary burials were common practice at the time, where the bones were removed after a year and placed in an ossuary (a stone bone box). In this case, however, the entrance to this part of the tomb was completely sealed with plaster. Prof. Spigelman believes this is due to the fact that this man had suffered from leprosy and died of tuberculosis, as the DNA of both diseases was found in his bones.

Historically, disfiguring diseases - particularly leprosy - caused the afflicted individuals to be ostracized from their communities. However, a number of indications the location and size of the tomb, the type of textiles used as shroud wrappings, and the clean state of the hair suggest that the shrouded individual was a fairly affluent member of society in Jerusalem and that tuberculosis and leprosy may have crossed social boundaries in the first century C.E.

Disproves Turin Shroud?

This is also the first time fragments of a burial shroud have been found from the time of Jesus in Jerusalem. The shroud is very different to that of the Turin Shroud, hitherto assumed to be the one that was used to wrap the body of Jesus. Unlike the complex weave of the Turin Shroud, this is made up of a simple two-way weave, as the textiles historian Dr. Orit Shamir was able to show.

Based on the assumption that this is representative of a typical burial shroud widely used at the time of Jesus, the researchers conclude that the Turin Shroud did not originate from Jesus-era Jerusalem.

The excavation also found a clump of the shrouded man's hair, which had been ritually cut prior to his burial. These are both unique discoveries because organic remains are hardly ever preserved in the Jerusalem area owing to high humidity levels in the ground.

Social health in antiquity

According to Prof. Spigelman and Prof. Greenblatt, the origins and development of leprosy are largely obscure. Leprosy in the Old Testament may well refer to skin rashes such as psoriasis. The leprosy known to us today was thought to have originated in India and brought over to the Near East and to Mediterranean countries in the Hellenistic period. The results from the first-century C.E. Tomb of the Shroud fill a vital gap in our knowledge of this disease.

Furthermore, the new research has shown that molecular pathology clearly adds a new dimension to the archaeological exploration of disease in ancient times and provides us with a better understanding of the evolution, geographic distribution and epidemiology of disease and social health in antiquity.

The co-infection of both leprosy and tuberculosis here and in 30 percent of DNA remains in Israel and Europe from the ancient and modern period provided evidence for the postulate that the medieval plague of leprosy was eliminated by an increased level of tuberculosis in Europe as the area urbanized.


'/>"/>

Contact: Rebecca Zeffert
rebeccaz@savion.huji.ac.il
972-548-820-661
The Hebrew University of Jerusalem
Source:Eurekalert  

Related medicine news :

1. UNESCO Chair Hosts Jews, Christians, and Muslims in Jerusalem Bioethics Conferences
2. Event Honoring Bill Gates Raises Over $1.5 Million for Sustainable Agriculture Research at The Hebrew University of Jerusalem
3. Robert H. Smith Feeding the Future with $15 Million Gift to Hebrew University of Jerusalem
4. Do Jerusalems Arabs and Jews receive a different quality of medical care?
5. Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs
6. Research reveals further progress toward AIDS vaccine
7. Beneath the Short White Coat: A Medical Student Reveals All
8. Northwestern Mutual Survey Reveals That Most Americans Are Putting Their Income at Risk
9. BenefitPackages.com Reveals the Truth About No or Low Cost Medicare Supplement Plan Options Including Anthem Blue Cross Freedom Blue Regional PPO
10. AIDS research reveals a lack of family-planning programs in Uganda
11. Study Reveals Evidence of Heart Disease in Ancient Egyptian Mummies
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... stories, which come courtesy of leaders in the nursing and health care industry. It ... advocates and associations—namely Abilene Christian University. , As the nursing industry is coming ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... (IP) to its specialty academic programs. , Answering to the increasing demand for ... programs in health law, and environmental and land use law. ,  , “The ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is ... impact on long-term patient survival, reports a team of UPMC researchers in the ... in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016 MedDay, ... disorders, announces that an oral presentation entitled "High doses of ... MS-SPI trial" will be given by Professor Ayman Tourbah ... 2nd Congress of the European Academy of Neurology (EAN) in ... and related disorders 3" will take place on Sunday, 29 ...
(Date:5/24/2016)... -- Cirujanos holandeses han puesto en marcha ... a compartir sus mejores prácticas por el mundo y ... de Europa, África, Asia y ... que combina la transmisión en vivo con mensajería instantánea ... Educación   "Imagine un médico de Medicines sans ...
(Date:5/24/2016)... May 24, 2016 ARANZ Medical ... the healthcare sector, has been named the Coretex Hi-Tech Emerging ... 2016. Dr Bruce Davey , CEO of ... team.  It,s really good to be recognised for the work ... products are used in 35 countries around the world from ...
Breaking Medicine Technology: